These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 29227930)

  • 41. Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.
    Boechat N; Ferreira VF; Ferreira SB; de Lourdes G Ferreira M; de C da Silva F; Bastos MM; Dos S Costa M; Lourenço MC; Pinto AC; Krettli AU; Aguiar AC; Teixeira BM; da Silva NV; Martins PR; Bezerra FA; Camilo AL; da Silva GP; Costa CC
    J Med Chem; 2011 Sep; 54(17):5988-99. PubMed ID: 21776985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis and in vitro anti-tuberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,2,3-triazole derivatives.
    Sajja Y; Vanguru S; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5119-5121. PubMed ID: 29113761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and In Vitro Antimycobacterial and Antibacterial Activity of 8-OMe Ciprofloxacin-Hydrozone/Azole Hybrids.
    Xu Z; Zhang S; Feng LS; Li XN; Huang GC; Chai Y; Lv ZS; Guo HY; Liu ML
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28703766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis.
    Venugopala KN; Dharma Rao GB; Bhandary S; Pillay M; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K
    Drug Des Devel Ther; 2016; 10():2681-90. PubMed ID: 27601885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
    Raja S; Prakash CR
    Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Malasala S; Ahmad MN; Akunuri R; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2021 Feb; 212():112996. PubMed ID: 33190958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and synthesis of benzo[b]thiophene-based hybrids as novel antitubercular agents against MDR/XDR Mycobacterium tuberculosis.
    Al-Warhi T; Rashad NM; Almahli H; Abdel-Aziz MM; Elsayed ZM; Shahin MI; Eldehna WM
    Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300529. PubMed ID: 37946574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
    Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents.
    Mohan Krishna K; Inturi B; Pujar GV; Purohit MN; Vijaykumar GS
    Eur J Med Chem; 2014 Sep; 84():516-29. PubMed ID: 25055342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl)fluoroquinolone derivatives.
    Chai Y; Wan ZL; Wang B; Guo HY; Liu ML
    Eur J Med Chem; 2009 Oct; 44(10):4063-9. PubMed ID: 19481308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-mycobacterial activity of plumericin and isoplumericin against MDR Mycobacterium tuberculosis.
    Kumar P; Singh A; Sharma U; Singh D; Dobhal MP; Singh S
    Pulm Pharmacol Ther; 2013 Jun; 26(3):332-5. PubMed ID: 23333815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Click chemistry approach for bis-chromenyl triazole hybrids and their antitubercular activity.
    Naik RJ; Kulkarni MV; Sreedhara Ranganath Pai K; Nayak PG
    Chem Biol Drug Des; 2012 Oct; 80(4):516-23. PubMed ID: 22737986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, antimicrobial, antibiofilm and computational studies of isatin-semicarbazone tethered 1,2,3-triazoles.
    Kumar A; Lal K; Kumar V; Murtaza M; Jaglan S; Paul AK; Yadav S; Kumari K
    Bioorg Chem; 2023 Apr; 133():106388. PubMed ID: 36736034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, Characterization, Antimicrobial and In Silico Studies of Isatin Schiff Base Linked 1,2,3-Triazole Hybrids.
    Kumar V; Bhukal A; Raman APS; Singh P; Lal K
    Chem Biodivers; 2024 Jul; 21(7):e202400569. PubMed ID: 38770783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice.
    Fattorini L; Tan D; Iona E; Mattei M; Giannoni F; Brunori L; Recchia S; Orefici G
    Antimicrob Agents Chemother; 2003 Jan; 47(1):360-2. PubMed ID: 12499213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
    Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
    Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of 4-amino-5-alkynylpyrimidine-2(1H)-ones as anti-mycobacterial agents.
    Garg G; Pande M; Agrawal A; Li J; Kumar R
    Bioorg Med Chem; 2016 Apr; 24(8):1771-7. PubMed ID: 26988804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 7-chloroquinoline-isatin conjugates: antimalarial, antitubercular, and cytotoxic evaluation.
    Raj R; Biot C; Carrère-Kremer S; Kremer L; Guérardel Y; Gut J; Rosenthal PJ; Forge D; Kumar V
    Chem Biol Drug Des; 2014 May; 83(5):622-9. PubMed ID: 24341638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and anti-mycobacterial activity of 4-(4-phenyl-1H-1,2,3-triazol-1-yl)salicylhydrazones: revitalizing an old drug.
    Abdu-Allah HH; Youssif BG; Abdelrahman MH; Abdel-Hamid MK; Reshma RS; Yogeeswari P; Aboul-Fadl T; Sriram D
    Arch Pharm Res; 2017 Feb; 40(2):168-179. PubMed ID: 28028696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.